Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new position in shares of Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 113,956 shares of the financial services provider’s stock, valued at approximately $21,141,000.
Several other large investors have also recently added to or reduced their stakes in the company. Welch & Forbes LLC purchased a new position in Marsh & McLennan Companies during the fourth quarter worth about $1,270,000. BNP Paribas Financial Markets acquired a new position in shares of Marsh & McLennan Companies during the 4th quarter valued at $267,251,000. Gulf International Bank UK Ltd bought a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth about $4,574,000. WASHINGTON TRUST Co bought a new stake in shares of Marsh & McLennan Companies in the 4th quarter worth about $19,034,000. Finally, Forsta AP Fonden acquired a new position in shares of Marsh & McLennan Companies in the 4th quarter valued at about $24,433,000. 87.99% of the stock is owned by hedge funds and other institutional investors.
Marsh & McLennan Companies Price Performance
MRSH stock opened at $159.73 on Monday. The company’s 50 day moving average price is $164.87. Marsh & McLennan Companies, Inc. has a 52-week low of $157.74 and a 52-week high of $235.78. The firm has a market capitalization of $77.17 billion, a price-to-earnings ratio of 19.97, a P/E/G ratio of 2.33 and a beta of 0.62. The company has a debt-to-equity ratio of 1.28, a current ratio of 1.11 and a quick ratio of 1.11.
Wall Street Analyst Weigh In
Several research firms have recently commented on MRSH. Bank of America decreased their price target on shares of Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating for the company in a report on Tuesday, April 14th. JPMorgan Chase & Co. reduced their target price on shares of Marsh & McLennan Companies from $226.00 to $206.00 and set an “overweight” rating for the company in a research note on Thursday, April 9th. Mizuho reduced their price target on shares of Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Wells Fargo & Company reduced their price target on shares of Marsh & McLennan Companies from $203.00 to $178.00 and set an “equal weight” rating for the company in a research note on Thursday, April 9th. Finally, Piper Sandler dropped their target price on shares of Marsh & McLennan Companies from $190.00 to $182.00 and set a “neutral” rating on the stock in a report on Tuesday, May 26th. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Marsh & McLennan Companies has an average rating of “Hold” and a consensus target price of $203.56.
View Our Latest Analysis on MRSH
Insider Buying and Selling
In other Marsh & McLennan Companies news, CEO John Q. Doyle sold 16,655 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $183.30, for a total value of $3,052,861.50. Following the completion of the sale, the chief executive officer directly owned 116,811 shares of the company’s stock, valued at $21,411,456.30. The trade was a 12.48% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. 0.38% of the stock is owned by corporate insiders.
Marsh & McLennan Companies Company Profile
Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.
The firm operates through several well-known subsidiaries and business units that specialize in distinct services.
See Also
- Five stocks we like better than Marsh & McLennan Companies
- These 3 CLO ETFs Target a Niche Corner of the Fixed-Income Market
- 3 Ways to Play the Data Center Land Grab
- The Smarter Way to Invest in AI Without Taking Extreme Risk
- 3 Dividend Kings That Earn Their Crown Every Quarter
Want to see what other hedge funds are holding MRSH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Marsh & McLennan Companies, Inc. (NYSE:MRSH – Free Report).
Receive News & Ratings for Marsh & McLennan Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marsh & McLennan Companies and related companies with MarketBeat.com's FREE daily email newsletter.
